PALO ALTO, Calif., Nov. 15 /PRNewswire-FirstCall/ -- TIBCO Software Inc. , a leading business integration and process management software company that enables real-time business, today announced that its customer -- Iconix Pharmaceuticals -- has been honored with an InfoWorld 100 Award for its creative use of TIBCO General Interface Framework. Iconix Pharmaceuticals' leveraged TIBCO's AJAX solution to develop and power an intuitive, high productivity graphical user interface (GUI) for its comprehensive DrugMatrix(R) database.

TIBCO General Interface is the industry's most mature Rich Internet Application (RIA) development solution based on Asynchronous communication, JavaScript and XML (AJAX) technology. Iconix first deployed DrugMatrix with the General Interface Framework in 2001 leveraging development techniques from AJAX technology.

TIBCO's powerful RIA framework and visual development tools enabled Iconix to bring together its vast array of chemogenomics data into a single, easy-to- use, highly interactive Web application that looked, felt and performed like desktop software, yet was instantly accessible through a standard Web browser. Additionally, Iconix relied on TIBCO's RIA offering to bring DrugMatrix, which includes over 180 AJAX-powered end user screens, to market far more quickly and cost-effectively than would have otherwise been possible through alternative software development models.

"Iconix is honored to be listed among the top IT innovators in the InfoWorld 100 for its pioneering use of AJAX," said Alan Roter, vice president of informatics, Iconix Pharmaceuticals. "Having gone into production with General Interface four years ago, we're proud of the fact that DrugMatrix is one of the most mature implementations of AJAX in the enterprise today. Further, by using TIBCO's AJAX-based RIA solution instead of a standard client/server architecture, we were able to develop DrugMatrix for about a third of the cost and bring it to market twice as fast."

DrugMatrix is the first comprehensive research tool in the new field of chemogenomics, enabling pharmaceutical company researchers to select the highest quality leads and drug candidates at the earliest, most cost-effective stages of drug discovery and development. Leading research and pharmaceutical companies, including Bristol-Myers Squibb and Abbott Laboratories, use DrugMatrix to increase the odds of advancing the right compounds to the clinic, reducing attrition rates and the costs of drug discovery.

The annual InfoWorld 100 Awards honor top IT projects that demonstrate the most creative use of cutting-edge technologies to further their business goals. Iconix is also one of 20 finalists in line for the InfoWorld 100 Project of the Year Award. Full text of the InfoWorld 100 Awards is available online at: http://infoworld.com/3573 .

About Iconix

Iconix Pharmaceuticals, Inc. is pioneering the new field of chemogenomics, the integration of chemistry and genomics to profile drug candidates. Iconix's chemogenomic capabilities enable pharmaceutical companies to increase the odds of advancing the right compounds to the clinic, reducing attrition rates and the costs of drug discovery. Iconix provides reference systems and know-how to predict toxic liabilities, side effects and mechanisms of drug candidates. The company has collaborations with Bristol Myers Squibb, Abbott Laboratories, ICOS, Eli Lilly, Schering-Plough, AstraZeneca, Taisho Pharmaceutical Co., Ltd., Eisai Co., Ltd. and other leading companies. Iconix also provides research, training and support to the U.S. Food and Drug Administration, Center for Drug Evaluation and Research (CDER) under an agreement to advance CDER's study of the application of genomic technologies in the regulatory approval process. Iconix's DrugMatrix system has been installed at the FDA for use by CDER scientists and reviewers in a diverse range of chemogenomics applications. The company also has strategic partnerships with leading life sciences companies including MDS Pharma Services and GE Healthcare.

Headquartered in Mountain View, California, Iconix was founded in 1998 and is privately held. For more information, visit http://www.iconixpharm.com/.

About TIBCO

TIBCO Software Inc. is a leading business integration and process management software company that enables real-time business. Real-Time Business is about helping companies become more cost-effective, more agile and more efficient. TIBCO has delivered the value of Real-Time Business, what TIBCO calls The Power of Now(R), to over 2,000 customers around the world and in a wide variety of industries. For more information on TIBCO's proven enterprise backbone, business integration, business process management, and business optimization solutions, TIBCO can be reached at +1-650-846-1000 or on the Web at http://www.tibco.com/. TIBCO is headquartered in Palo Alto, CA.

NOTE: TIBCO, the TIBCO logo, The Power of Now, TIBCO General Interface and TIBCO Software are trademarks or registered trademarks of TIBCO Software Inc. in the United States and/or other countries.

All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.

CONTACT: Holly Lawrence of TIBCO Software, +1-650-846-8463, or
hlawrenc@tibco.com, or Bill Bourdon of Bateman Group, +1-415-602-1491, or
bbourdon@bateman-group.com, for TIBCO Software Inc.

Web site: http://www.tibco.com/